Successful Treatment of Trichotillomania with Olanzapine Augmentation in an Adolescent [1]

Journal of Child and Adolescent Psychopharmacology

Volumn 14, Issue 1, 2004, Pages 153-154

  Pathak, Sanjeev ^a,b   Danielyan, Arman ^a   Kowatch, Robert A ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; OLANZAPINE; PAROXETINE; SERTRALINE;

ADOLESCENT; ANAMNESIS; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; CASE REPORT; FEMALE; HUMAN; LETTER; MUTISM; PSYCHOTHERAPY; SIDE EFFECT; SOCIAL PHOBIA; SYMPTOM; TRICHOTILLOMANIA; WEIGHT GAIN;

ADOLESCENT; BEHAVIOR THERAPY; BENZODIAZEPINES; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; PAROXETINE; SERTRALINE; TRICHOTILLOMANIA;

EID: 1942539085     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454604773840616     Document Type: Letter

References (6)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision (DSM-IV-TR). Washington (DC), American Psychiatric Association, 2000.
2. Dietz WH: Health consequences of obesity in youth: Childhood predictors of adult disease. Pediatrics 101:518-525, 1998.
3. Epperson CN, Fasula D, Wasylink S, Price LH, McDougle CJ: Risperidone addition in serotonin re-uptake inhibitor-resistant trichotillomania: Three cases. J Child Adolesc Psychopharmacol 9:43-49, 1999.
4. Koran LM, Ringold A, Hewlett W: Fluoxetine for trichotillomania: An open clinical trial. Psychopharmacol Bull 28:145-149, 1992.
5. Stewart RS, Nejtek VA: An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. J Clin Psychiatry 64:49-52, 2003.
6. Streichenwein SM, Thornby JI: A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry 152:1192-1196, 1995.